Molecular progress in infertility: Polycystic ovary syndrome

Fertility and Sterility

Volumn 78, Issue 3, 2002, Pages 569-576

  Legro, Richard S ^a   Strauss III, Jerome F ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Family studies; Genetics; Insulin resistance; Linkage; Polycystic ovary syndrome

Indexed keywords

INSULIN;

FAMILY STUDY; FEMALE; FEMALE INFERTILITY; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0036734026     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03275-2     Document Type: Article

References (70)

1. Polycystic ovaries-a common finding in normal women
2. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women
3. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States; a prospective study
4. A survey of the polycystic ovary syndrome in the Greek island of Lesbos; hormonal and metabolic profile
5. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain
6. Anovulation after precocious pubarche; early markers and time course in adolescence
7. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing
8. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome
9. DNA polymorphism and the study of disease associations
10. Familial polycystic ovarian disease
11. The inheritance of polycystic ovarian disease and a possible relationship to premature balding
12. Familial clustering in the polycystic ovarian syndrome
13. Familial polycystic ovaries; a genetic disease?
14. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
15. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
16. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
17. Polycystic ovaries are inherited as an autosomal dominant trait; analysis of 29 polycystic ovary syndrome and 10 control families
18. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS
19. Familial clustering of insulin and abdominal visceral fat; the Heritage family study
20. Steroid, follicle-stimulating hormone, and luteinizing hormone profiles in identical twins with polycystic ovaries
21. Polycystic ovarian syndrome in identical twins
22. A twin study of polycystic ovary syndrome
23. Tetraploidy in two sisters with the polycystic ovary syndrome
24. C-band polymorphism of chromosome No. 1 in patients with polycystic ovary disease
25. Association of polycystic ovary syndrome with an interstitial deletion of the long arm of chromosome 11
26. Cytogenetic evaluation of 41 patients with Stein-Leventhal syndrome
27. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries
28. Hyperexpression of epidermal growth factor receptors in granulosa cells from women with polycystic ovary syndrome
29. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism
30. Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene cyp11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome
31. Thirty-seven candidate genes for polycystic ovary sydnrome; strongest evidence for linkage is with follistatin
32. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the cyp11a gene in the pathogenesis of hirsutism
33. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
34. 5′ polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries
35. 17 alpha-hydroxylase/17,20-lyase dysregulation is not caused by mutations in the coding regions of cyp17
36. The presence of the 21-hydroxylase deficiency carrier status in hirsute women; phenotype-genotype correlations
37. The role of heterozygosity for cyp21 in the polycystic ovary syndrome
38. Androgen receptor gene cag trinucleotide repeats in anovulatory infertility and polycystic ovaries
39. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction
40. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism
41. Insulin resistance and the polycystic ovary syndrome; mechanism and implications for pathogenesis
42. Potential role of tnf-alpha in the pathogenesis of insulin resistance and type 2 diabetes
43. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
44. Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus
45. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
46. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome
47. Role of allelic variants gly972arg of irs-1 and gly1057asp of irs-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome
48. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome
49. Association of acci polymorphism in the follicle-stimulating hormone beta gene with polycystic ovary syndrome
50. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome
51. A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female Hispanics
52. Dopamine d3 receptor polymorphism is not associated with the polycystic ovary syndrome
53. Allelic variants of the follistatin gene in polycystic ovary syndrome
54. HLA genotyping in family members and patients with familial polycystic ovarian disease
55. HLA associations in patients with polycystic ovaries and in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency
56. Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501
57. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome
58. Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome
59. Deleterious missense mutations and silent polymorphism in the human 17 beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3)
60. Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the x chromosome, gene-1 (dax-1), in hyperandrogenic hirsute women
61. Polymorphism of glycogen synthetase gene in polycystic ovary syndrome
62. A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome
63. No association between the -308 polymorphism in the tumour necrosis factor alpha (tnf alpha) promoter region and polycystic ovaries
64. No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome
65. Role of the mutations trp8→arg and ile15→thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome
66. Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome
67. Association of dopamine D2 receptor gene haplotypes with anovulation and fecundity in female Hispanics
68. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries
69. Differential activity of the cytochrome p450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells